{"id":207983,"name":"APELLIS PHARMACUETICALS","slug":"apellis-pharmacueticals","state":"MA","country":"United States of America","description":"biopharmaceutical company that develops therapies for hematology, ophthalmology, etc.","totalSpending":200000,"filings":13,"yearlySpending":[{"year":2020,"income":0},{"year":2021,"income":80000},{"year":2022,"income":80000},{"year":2023,"income":40000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"MED","display":"Medical/Disease Research/Clinical Labs"}],"firms":["ACUITY STRATEGIC PARTNERS LLC"],"lobbyists":["MICHAEL EGING"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medicare reimbursement , Cell and Gene therapy research","Medicare reimbursement , Cell and Gene therapy research","Medicare reimbursement , Cell and Gene therapy research","Medicare reimbursement , Cell and Gene therapy research","Medicare reimbursement , Cell and Gene therapy research"]}